Intravenous pamidronate for refractory rheumatoid arthritis

Intravenous pamidronate for refractory rheumatoid arthritis

Background: Patients with rheumatoid arthritis may be resistant to conventional treatment with disease-modifying antirheumatic drugs (DMARDs). On the other hand, biologic therapy is costly and may be inconvenient for many patients. Pamidronate is a potent bisphosphonate with the capacity of modifyin...

Full description

Bibliographic Details
Main Authors: Mansour Salesi, Peyman Mottaghi, Mansour Karimifar, Ziba Farajzadegan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Rheumatoid Arthritis
Refractory
Pamidronate.
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=5;spage=422;epage=427;aulast=Salesi

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=5;spage=422;epage=427;aulast=Salesi

Similar Items